D-0868-2017 Class III Terminated
FDA drug recall D-0868-2017 was initiated by Sandoz Inc on Apr 26, 2017 and is designated Class III. Reason for recall: Subpotent Drug; Clavulanic Acid The recall status is terminated (terminated Aug 19, 2019). Affected quantity: 4,464 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 7, 2017
- Initiation Date
- Apr 26, 2017
- Termination Date
- Aug 19, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,464 bottles
Product description
Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20
Reason for recall
Subpotent Drug; Clavulanic Acid
Distribution pattern
NY, OH
Code information
Lot FP8735, 8/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0868-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026